New approach aims to catch kidney disease earlier in hispanic and black communities

NCT ID NCT05734989

Completed Knowledge-focused Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study worked with community groups to screen Hispanic/Latinx adults for kidney disease and diabetes, then referred them to a primary care doctor. It also gave local clinics guidelines to help doctors screen and treat Hispanic and Black patients with diabetes. The goal was to see if these steps could improve early detection and proper treatment, and ultimately slow kidney disease in these groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this approach could help slow kidney disease progression in high-risk communities and be scaled to other regions.
What could go wrong: This is a completed pilot study with 248 participants in one city, so results may not apply broadly. The intervention relies on referrals and guidelines, not a new drug or therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASES TYPE 2 DIABETES

Contacts and locations

Locations

Duke University Medical Center

Durham, North Carolina, 27708, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.